Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study.

Kristina Stuopelyte Arnas Bakavicius Juozas Rimantas Lazutka Albertas Ulys Feliksas Jankevicius Sonata Jarmalaite

Published in: The Prostate (2021)

Urinary miRNAs could be used as prognostic biomarkers for CRPC patients to predict response to AA therapy, especially for the cases with high blood AR levels.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
patient reported